Literature DB >> 17503876

New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Martijn A Spruit1, Emiel F M Wouters.   

Abstract

Pulmonary rehabilitation has been shown to be an important part of the management of patients with chronic obstructive pulmonary disease (COPD). Exercise training is the corner stone of a comprehensive, multidisciplinary pulmonary rehabilitation in COPD and has been shown to improve health-related quality of life and exercise capacity. Nevertheless, not every COPD patient responds well to pulmonary rehabilitation. Future trials should focus on new additions to conventional pulmonary rehabilitation programmes to optimise its effects on health-related quality of life, exercise capacity, body composition and muscle function in patients with COPD. Therefore, a patient-tailored approach is inevitable. Advantages and disadvantages of new modalities of pulmonary rehabilitation will be outlined in detail, including the following: endurance training and long-acting bronchodilatators; endurance training and technical modalities (inspiratory pressure support and inspiratory muscle training); interval training; resistance training; transcutaneous neuromuscular electrical stimulation; and exercise training and supplements (oxygen, oral creatine, anabolic steroids and polyunsaturated fatty acids). Based on well defined baseline characteristics, patients should most probably be individually selected. At present, these new modalities of pulmonary rehabilitation have been shown to improve body composition, skeletal muscle function and sometimes also exercise capacity. However, the translation to an improved health-related quality of life is mostly lacking, and cost effectiveness and long-term effects have not been studied. Moreover, future trials should study the effects of pulmonary rehabilitation in elderly patients with restrictive pulmonary diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17503876     DOI: 10.2165/00007256-200737060-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  154 in total

Review 1.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

2.  Pulmonary rehabilitation and the BODE index in COPD.

Authors:  C G Cote; B R Celli
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

3.  Long-term creatine intake is beneficial to muscle performance during resistance training.

Authors:  K Vandenberghe; M Goris; P Van Hecke; M Van Leemputte; L Vangerven; P Hespel
Journal:  J Appl Physiol (1985)       Date:  1997-12

Review 4.  Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.

Authors:  Denis E O'Donnell
Journal:  Proc Am Thorac Soc       Date:  2006-04

5.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

Authors:  A L Hamilton; K J Killian; E Summers; N L Jones
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

6.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.

Authors:  Frans H Rutten; Maarten-Jan M Cramer; Diederick E Grobbee; Alfred P E Sachs; Johannes H Kirkels; Jan-Willem J Lammers; Arno W Hoes
Journal:  Eur Heart J       Date:  2005-04-28       Impact factor: 29.983

7.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Authors:  Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

8.  Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

Authors:  J A van Noord; J-L Aumann; E Janssens; J J Smeets; J Verhaert; B Disse; A Mueller; P J G Cornelissen
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

9.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

10.  Acute effects of inspiratory pressure support during exercise in patients with COPD.

Authors:  A van 't Hul; R Gosselink; P Hollander; P Postmus; G Kwakkel
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

View more
  3 in total

1.  Oxygen uptake, ventilation, and symptoms during low-frequency versus high-frequency NMES in COPD: a pilot study.

Authors:  Maurice J H Sillen; Emiel F M Wouters; Frits M E Franssen; Kenneth Meijer; Koen H P Stakenborg; Martijn A Spruit
Journal:  Lung       Date:  2010-11-16       Impact factor: 2.584

2.  Clinical highlights from the 2011 ERS Congress in Amsterdam.

Authors:  Martijn A Spruit; Niels H Chavannes; Felix J F Herth; Venerino Poletti; Sebastian Ley; Otto C Burghuber; Enrico Clini; Vincent Cottin
Journal:  Eur Respir J       Date:  2012-03-09       Impact factor: 16.671

3.  Metabolic load during strength training or NMES in individuals with COPD: results from the DICES trial.

Authors:  Maurice J H Sillen; Frits M E Franssen; Anouk W Vaes; Jeannet M L Delbressine; Emiel F M Wouters; Martijn A Spruit
Journal:  BMC Pulm Med       Date:  2014-09-02       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.